Editoria e Media
Sexually Transmitted Diseases (STD) Testing Market to Reach $150.44 Billion, Globally, by 2030 at 5.1% CAGR: AMR
For Right Perspective and Competitive Insights, Get Sample Report at:
https://www.alliedmarketresearch.com/request-sample/385
High prevalence and rise in incidences of STDs, supporting reimbursement for STDs testing, and implementation of national screening programs have boosted the growth of the global sexually transmitted diseases (STD) testing market. However, huge proportion of patients infected with STDs in remote areas, stringent regulatory abidance requirements for the participants of the STD market, huge number of patients infected with STDs in remote areas, and social stigma associated with patients visiting specialized STD clinics hinder the market growth. On the contrary, reduction in the number of visits to government clinics, national screening programs, and advancements in technology and POC tests are expected to open new opportunities in the future.
By disease type, the gonorrhea segment is expected to manifest the highest CAGR of 7.3% during the forecast period. However, the chlamydia testing segment dominated the market in 2020, accounting for more than one-fourth of the market, due to lack of awareness about sexually transmitted diseases among population and lack of barrier protection.
https://www.alliedmarketresearch.com/purchase-enquiry/385
By location of testing, the laboratory testing segment held the lion's share in 2020, contributing to more than four-fifths of the market, as most of the cases of diagnostic testing are carried out in the labs. However, the point of care testing segment is anticipated to register the highest CAGR of 6.3% from 2021 to 2030, due to untapped markets in developing countries.
By region, Asia-Pacific , followed by LAMEA and North America , dominated the market in 2020, contributing to more than half of the market. Moreover, the region is expected to portray the highest CAGR of 5.3% during the forecast period, owing to increase in case of sexual transmitted diseases in emerging countries and rise in patient awareness through education campaigns.
Sign up for Avenue subscription to access more than 12,000+ company profiles and 2,000+ niche industry market research reports at $699 per month, per seat. For a year, the client needs to purchase minimum 2 seat plan.
https://www.alliedmarketresearch.com/avenue/trial/starter
HIV Drugs Market - Global Opportunity Analysis and Industry Forecast, 2020–2030
Minimally Invasive Surgical Market - Global Opportunity Analysis and Industry Forecast, 2020-2030
Surgical Robots Market - Global Opportunity Analysis and Industry Forecast, 2020-2030
Medical Spa Market - Global Opportunity Analysis and Industry Forecast, 2020–2030
Orthodontics Market - Global Opportunity Analysis and Industry Forecast, 2020–2030
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon . Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
+1-800-792-5285, +1-503-894-6022
+44-845-528-1300
+852-301-84916
+91-20-66346060
+1(855)550-5975
help@alliedmarketresearch.com
https://www.alliedmarketresearch.com/reports-store/life-sciences
https://www.linkedin.com/showcase/life-sciences-industry-research/
Logo: https://mma.prnewswire.com/media/636519/Allied_Market_Research_Logo